HomeCompareBKIMF vs MRK

BKIMF vs MRK: Dividend Comparison 2026

BKIMF yields 3.60% · MRK yields 2.76%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 BKIMF wins by $1033.06M in total portfolio value
10 years
BKIMF
BKIMF
● Live price
3.60%
Share price
$16.41
Annual div
$0.59
5Y div CAGR
100%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$1033.12M
Annual income
$980,718,058.71
Full BKIMF calculator →
MRK
Merck & Co. Inc.
● Live price
2.76%
Share price
$120.31
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$56.8K
Annual income
$9,798.13
Full MRK calculator →

Portfolio growth — BKIMF vs MRK

📍 BKIMF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodBKIMFMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, BKIMF + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
BKIMF pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

BKIMF
Annual income on $10K today (after 15% tax)
$305.61/yr
After 10yr DRIP, annual income (after tax)
$833,610,349.90/yr
MRK
Annual income on $10K today (after 15% tax)
$234.56/yr
After 10yr DRIP, annual income (after tax)
$8,328.41/yr
At 15% tax rate, BKIMF beats the other by $833,602,021.49/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of BKIMF + MRK for your $10,000?

BKIMF: 50%MRK: 50%
100% MRK50/50100% BKIMF
Portfolio after 10yr
$516.59M
Annual income
$490,363,928.42/yr
Blended yield
94.92%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

BKIMF
Analyst Ratings
1
Buy
3
Hold
Consensus: Hold
Altman Z
-0.7
Piotroski
3/9
MRK
Analyst Ratings
25
Buy
11
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+6.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

BKIMF buys
0
MRK buys
0
No recent congressional trades found for BKIMF or MRK in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricBKIMFMRK
Forward yield3.60%2.76%
Annual dividend / share$0.59$3.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR100%32.7%
Portfolio after 10y$1033.12M$56.8K
Annual income after 10y$980,718,058.71$9,798.13
Total dividends collected$1029.33M$28.9K
Payment frequencyquarterlyquarterly
SectorStockHealthcare
Analyst consensusHoldBuy

Year-by-year: BKIMF vs MRK ($10,000, DRIP)

YearBKIMF PortfolioBKIMF Income/yrMRK PortfolioMRK Income/yrGap
1← crossover$11,419$719.08$11,206$366.19+$213.00BKIMF
2$13,753$1,534.81$12,650$502.35+$1.1KBKIMF
3$18,171$3,455.22$14,407$694.19+$3.8KBKIMF
4$27,976$8,532.96$16,585$967.82+$11.4KBKIMF
5$54,490$24,555.58$19,342$1,363.89+$35.1KBKIMF
6$147,702$89,397.63$22,913$1,947.19+$124.8KBKIMF
7$610,982$452,940.86$27,662$2,823.89+$583.3KBKIMF
8$4,155,861$3,502,110.79$34,159$4,173.35+$4.12MBKIMF
9$48,972,270$44,525,497.92$43,337$6,308.80+$48.93MBKIMF
10$1,033,118,387$980,718,058.71$56,776$9,798.13+$1033.06MBKIMF

BKIMF vs MRK: Complete Analysis 2026

BKIMFStock

Bankinter, S.A. provides various banking products and services to individuals and corporate customers, and small- and medium-sized enterprises in Spain. It offers salary, non-salary, professional, basic, currency, pension, business, and current accounts, as well as deposit products; and mortgages and loan products, as well as financing services. The company also provides saving and investment products, including profiled funds, sustainable investment funds, other managers funds, pension funds, and themed funds, as well as funds for beginners; regular investment plans; and advisory, customized investment, wealth management, and alternative investment products and services. In addition, it offers accident, home, life, funeral, health, mortgage payment protection, property, personal, and motor insurance products, as well as business insurance products. Further, the company provides various services, such as estate administration, switch, asset management, accounts management, and transfer services, as well as real estate and brokerage services. The company also offers retail, personal, private, commercial, and corporate banking products, as well as remote banking services. As of December 31, 2021, it operated through a network of 446 branches and 379 agents. The company was formerly known as Banco Intercontinental Español, S.A. and changed its name to Bankinter, S.A. in July 1990. The company was founded in 1965 and is headquartered in Madrid, Spain.

Full BKIMF Calculator →

MRKHealthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this BKIMF vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

BKIMF vs SCHDBKIMF vs JEPIBKIMF vs OBKIMF vs KOBKIMF vs MAINBKIMF vs JNJBKIMF vs ABBVBKIMF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.